Ligand Announces Market Launch of Bazedoxifene in Japan and Spain for the Treatment of Postmenopausal Osteoporosis October 13, 2010
Ligand to Divest Combinatorial Compound Library and Screening Technology for $1.8 Million October 7, 2010